101 related articles for article (PubMed ID: 10765095)
21. Different responses in little and bigbig prolactin to metoclopramide in subjects with hyperprolactinemia due to 150-170 kD (bigbig) prolactin.
Bjøro T; Johansen E; Frey HH; Turter A; Torjesen PA
Acta Endocrinol (Copenh); 1993 Apr; 128(4):308-12. PubMed ID: 8498149
[TBL] [Abstract][Full Text] [Related]
22. [Metoclopramide test in the patients with hyperprolactinemia due to end-stage renal failure].
Niemczyk S; Matuszkiewicz-Rowńska J; Szamotulska K; Sitkowska-Kurzec Z; Gomółka M; Stopiński M; Grochowski J; Niemczyk L; Ostrowski G; Kulicki P
Pol Arch Med Wewn; 2006 Dec; 116(6):1144-9. PubMed ID: 18634523
[TBL] [Abstract][Full Text] [Related]
23. Influence of thyroid status on dopaminergic inhibition of thyrotropin and prolactin secretion: evidence for an additional feedback mechanism in the control of thyroid hormone secretion.
Feek CM; Sawers JS; Brown NS; Seth J; Irvine WJ; Toft AD
J Clin Endocrinol Metab; 1980 Sep; 51(3):585-9. PubMed ID: 7410535
[TBL] [Abstract][Full Text] [Related]
24. Galanin positively modulates prolactin secretion in normal women.
Grottoli S; Arvat E; Gianotti L; Ramunni J; Di Vito L; Maccagno B; Ciccarelli E; Camanni F; Ghigo E
J Endocrinol Invest; 1996 Dec; 19(11):739-44. PubMed ID: 9061507
[TBL] [Abstract][Full Text] [Related]
25. Prolactin secretion by metoclopramide in man.
Judd SJ; Lazarus L; Smythe G
J Clin Endocrinol Metab; 1976 Aug; 43(2):313-7. PubMed ID: 7571
[TBL] [Abstract][Full Text] [Related]
26. Mechanism of verapamil calcium channel blockade-induced hyperprolactinemia.
Kelley SR; Kamal TJ; Molitch ME
Am J Physiol; 1996 Jan; 270(1 Pt 1):E96-100. PubMed ID: 8772480
[TBL] [Abstract][Full Text] [Related]
27. Effects of hypothalamic dopamine (DA) on salsolinol (SAL)-induced prolactin (PRL) secretion in male goats.
Jin J; Hara S; Sawai K; Fülöp F; Nagy GM; Hashizume T
Anim Sci J; 2014 Apr; 85(4):461-7. PubMed ID: 24329779
[TBL] [Abstract][Full Text] [Related]
28. Stress-mediated effect of metoclopramide on cortisol secretion in man.
Nishida S; Matsuki M; Nagase Y; Horino M; Endoh M; Kakita K; Tenku A; Oyama H
J Clin Endocrinol Metab; 1983 Apr; 56(4):839-43. PubMed ID: 6300168
[TBL] [Abstract][Full Text] [Related]
29. Acute effects of L-dopa and bromocriptine on serum PRL, LH and FSH levels in patients with hyperprolactinemic and normoprolactinemic polycystic ovary syndrome.
Prelević GM; Würzburger MI; Perić LA
J Endocrinol Invest; 1987 Aug; 10(4):389-95. PubMed ID: 3119696
[TBL] [Abstract][Full Text] [Related]
30. Development of anti-PRL (prolactin) autoantibodies by homologous PRL in rats: a model for macroprolactinemia.
Hattori N; Nakayama Y; Kitagawa K; Li T; Inagaki C
Endocrinology; 2007 May; 148(5):2465-70. PubMed ID: 17303669
[TBL] [Abstract][Full Text] [Related]
31. Synchronous secretion of luteinizing hormone and prolactin in the human luteal phase: neuroendocrine mechanisms.
Braund W; Roeger DC; Judd SJ
J Clin Endocrinol Metab; 1984 Feb; 58(2):293-7. PubMed ID: 6420434
[TBL] [Abstract][Full Text] [Related]
32. Age-related changes in the metoclopramide-induced prolactin release in nulliparous women.
Parra A; Alarcón J; Gaviño F; Ramírez A; Espinosa de los Monteros A
Fertil Steril; 1993 Jul; 60(1):34-9. PubMed ID: 8513956
[TBL] [Abstract][Full Text] [Related]
33. Growth hormone and prolactin secretion after metoclopramide administration (DA2 receptor blockade) in fertile women.
Cunha-Filho JS; Gross JL; Vettori D; Dias EC; Passos EP
Horm Metab Res; 2001 Sep; 33(9):536-9. PubMed ID: 11561213
[TBL] [Abstract][Full Text] [Related]
34. Effect of parity on pituitary prolactin response to metoclopramide and domperidone: implications for the enhancement of lactation.
Brown TE; Fernandes PA; Grant LJ; Hutsul JA; McCoshen JA
J Soc Gynecol Investig; 2000; 7(1):65-9. PubMed ID: 10732318
[TBL] [Abstract][Full Text] [Related]
35. Histaminergic regulation of prolactin secretion: dose-response relationship and possible involvement of the dopaminergic system.
Knigge U; Thuesen B; Christiansen PM
J Clin Endocrinol Metab; 1986 Mar; 62(3):491-6. PubMed ID: 3944233
[TBL] [Abstract][Full Text] [Related]
36. Hyperprolactinemia after neonatal prolactin (PRL) deficiency in rats: evidence for altered anterior pituitary regulation of PRL secretion.
Shah GV; Shyr SW; Grosvenor CE; Crowley WR
Endocrinology; 1988 May; 122(5):1883-9. PubMed ID: 3129278
[TBL] [Abstract][Full Text] [Related]
37. A serotonergic mechanism of the prolactin-stimulating action of metoclopramide.
Fang VS; Shian LR
Endocrinology; 1981 May; 108(5):1622-7. PubMed ID: 6452260
[TBL] [Abstract][Full Text] [Related]
38. [Increased secretion of prolactin after inhibition of dopaminergic receptors by metoclopramide in patients with cancer of the prostate].
Baranowska B; Jeske W; Szymanowski J; Piechna K
J Urol (Paris); 1983; 89(8):601-5. PubMed ID: 6203986
[TBL] [Abstract][Full Text] [Related]
39. Efficacy of bromocriptine in the treatment of metastatic breast cancer- and prostate cancer-related hyperprolactinemia.
Lissoni P; Mandalà M; Giani L; Malugani F; Secondino S; Zonato S; Rocco F; Gardani G
Neuro Endocrinol Lett; 2000; 21(5):405-408. PubMed ID: 11452236
[TBL] [Abstract][Full Text] [Related]
40. Effect of ghrelin and metoclopramide on prolactin secretion in normal women.
Messini CI; Dafopoulos K; Chalvatzas N; Georgoulias P; Anifandis G; Messinis IE
J Endocrinol Invest; 2011 Apr; 34(4):276-9. PubMed ID: 20530986
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
